GYSERDIS
Live / Allowed — Second extension granted (statement of use) (as of 20 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99102713
- Mark type
- Word mark
- Filed
- 25 Mar 2025
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Gregory Zinkl
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 21 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2026 — SOU EXTENSION 2 GRANTED
- 20 Oct 2026 — SOU EXTENSION 2 FILED
- 20 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2026 — SOU EXTENSION 1 GRANTED
- 29 Apr 2026 — SOU EXTENSION 1 FILED
- 29 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT